NCT00261001View on ClinicalTrials.gov

Safety Study Comparing a Vaccine Transcutaneous Administration to the Intramuscular Route

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

February 28, 2006

Study Completion Date

September 30, 2009

Conditions
Healthy VolunteersHIV Infection
Interventions
BIOLOGICAL

Transcutaneous mode of administration

BIOLOGICAL

Intramuscular mode of administration

Trial Locations (2)

10117

Charité - Universitätsmedizin Berlin, Berlin

60590

Hospital of the Johann Wolfgang Goethe-University Frankfurt am Main, Frankfurt

All Listed Sponsors
lead

Objectif Recherche Vaccins SIDA

OTHER

NCT00261001 - Safety Study Comparing a Vaccine Transcutaneous Administration to the Intramuscular Route | Biotech Hunter | Biotech Hunter